🏛️ Palantir is basically federal

Good evening. Trump lashed out at China in a Truth Social post, accusing it of violating their trade deal and reports. Reports surfaced that the U.S. plans to expand tech sanctions by targeting subsidiaries of blacklisted firms.

⬆︎⬇︎ 1-day change
Market data: today’s market close

WINNERS

⬆︎9.72% Unity

Jefferies upgraded the game engine company from Hold to Buy, citing strong momentum from its Vector ad platform. Vector is Unity’s new ad targeting model that’s boosting app installs and in-app purchases by 15–20%. [Read more]

⬆︎7.73% Palantir

Palantir’s getting too comfy in D.C. The Trump administration has tapped the data analytics company to lead a new project aimed at unifying data systems across key federal agencies like the IRS and DHS. This move further expands Palantir’s growing footprint within the U.S. government. [Read more]

⬆︎3.12% Costco

🛎️ Earnings report - Built different. Not only did the bulk retail powerhouse report strong revenue and profit numbers last quarter, analysts say its flexible product mix and steady membership revenue help it handle economic uncertainty and tariffs better than most retailers. [Read more]

⬆︎⬇︎ 1-day change
Market data: today’s market close

IN PARTNERSHIP WITH PACASO

The key to a $1.3T opportunity

A new trend in real estate is making the most expensive properties obtainable. It’s called co-ownership, and it’s revolutionizing the $1.3T vacation home market.

The company leading the trend? Pacaso. Created by the founder of Zillow, Pacaso turns underutilized luxury properties into fully-managed assets and makes them accessible to the broadest possible market.

The result? More than $1b in transactions, 2,000+ happy homeowners, and over $110m in gross profits for Pacaso.

With rapid international growth and 41% gross profit growth last year, Pacaso is ready for what’s next. They even recently reserved the Nasdaq ticker PCSO.

But the real opportunity is now, before public markets. Until 5/29, you can join leading investors like SoftBank and Maveron for just $2.80/share.

Invest in Pacaso today.

_{This is a paid advertisement for Pacaso’s Regulation A offering. Please read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals. Under Regulation A+, a company has the ability to change its share price by up to 20%, without requalifying the offering with the SEC.}

LOSERS

⬇︎19.01% Regeneron

Regeneron and Sanofi just ran into trouble with their new COPD drug. One late-stage study showed the drug helped reduce flare-ups in patients with “smoker’s lung,” but a second study didn’t show enough benefit. That means approval from the FDA is unclear, and the drug will likely face a delay of 2–3 years. [Read more]

⬇︎20.18% Gap

🛎️ Earnings report - Old Navy can’t carry the load. The clothing retailer did actually beat expectations on profit and revenue last quarter. Old Navy led the way, but Banana Republic and Athleta continue to struggle. The concerning part? Tariffs could cost between $100 to $150 million this year, AKA a big chunk of their profits. [Read more]

⬆︎⬇︎ 1-day change
Market data: today’s market close

EXTRA

THE END

That’s it for today’s recap. We hope you found it valuable.

• Have any feedback? We’d love to hear from you. Just reply to this email.

• Was this email forwarded to you? Subscribe to our newsletter so you can stay updated on stock movers every day.

• Missed our previous newsletters? You can catch up on them here.

• Interested in advertising with us? Reply to this email, and we’ll take it from there.